CRIP1 functions as an oncogene in acute myeloid leukemia by modulating glycolytic metabolic reprogramming.

Sci Rep · 2026 · PMC13243662 · PMID 41986400

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

In control cells (SCR), 2-DG treatment resulted in reduced glucose consumption compared to untreated SCR cells (SCR-UT), though this difference did not reach statistical significance ( p = 0.08 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.